0001567619-19-018032.txt : 20190909
0001567619-19-018032.hdr.sgml : 20190909
20190909122112
ACCESSION NUMBER: 0001567619-19-018032
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190906
FILED AS OF DATE: 20190909
DATE AS OF CHANGE: 20190909
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Karas Kevin R
CENTRAL INDEX KEY: 0001522907
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35929
FILM NUMBER: 191082461
MAIL ADDRESS:
STREET 1: C/O NATIONAL RESEARCH CORPORATION
STREET 2: 1245 Q STREET
CITY: LINCOLN
STATE: NE
ZIP: 68508
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NATIONAL RESEARCH CORP
CENTRAL INDEX KEY: 0000070487
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 470634000
STATE OF INCORPORATION: WI
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1245 Q STREET
CITY: LINCOLN
STATE: NE
ZIP: 68508
BUSINESS PHONE: 4024752525
MAIL ADDRESS:
STREET 1: 1245 Q STREET
CITY: LINCOLN
STATE: NE
ZIP: 68508
4
1
doc1.xml
FORM 4
X0306
4
2019-09-06
0
0000070487
NATIONAL RESEARCH CORP
NRC
0001522907
Karas Kevin R
C/O NATIONAL RESEARCH CORPORATION
1245 "Q" STREET
LINCOLN
NE
68508
0
1
0
0
SVP Finance, CFO, Treas & Secy
Common Stock
2019-09-06
4
S
0
2902
62.8317
D
17576
D
Employee Stock Option (right to buy)
14.50
2023-01-07
Common Stock
20088
20088
D
Employee Stock Option (right to buy)
18.80
2024-01-07
Common Stock
5334
5334
D
Employee Stock Option (right to buy)
13.17
2025-01-06
Common Stock
19313
19313
D
Employee Stock Option (right to buy)
15.23
2026-01-05
Common Stock
20458
20458
D
Employee Stock Option (right to buy)
18.8
2027-01-04
Common Stock
16728
16728
D
Employee Stock Option (right to buy)
36.8
2028-01-03
Common Stock
11617
11617
D
Employee Stock Option (right to buy)
38.30
2029-01-03
Common Stock
11162
11162
D
The price in Column 4 is a weighted average price. The prices actually received ranged from $62.30 to $63.165. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.
This option became fully exercisable on January 7, 2018.
This option became fully exercisable on January 7, 2019.
This option becomes fully exercisable on January 6, 2020.
This option becomes fully exercisable on January 5, 2021.
This option becomes fully exercisable on January 4, 2022.
This option becomes fully exercisable on January 3, 2023.
This option becomes fully exercisable on January 3, 2024.
/s/ Russell E. Ryba, Attorney-In-Fact for Kevin R. Karas
2019-09-09